Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1123-1127

  Brattstrom D ^a   Bergqvist, M ^a   Larsson, A ^a   Holmertz, J ^a   Hesselius, P ^a   Rosenberg, L ^a   Brodin, O ^a   Wagenius, G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

bFGF; NSCLC; Prognosis; Serum; Survival; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031841108     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bicknell R, Harris AL: Novel growth regulatory factors and tumor angiogenesis. Eur J Cancer 27: 781 -85, 1991.
2. Fox SB, Gatter KC, Harris AL: Tumour angiogenesis: review article. J of Pathology 179: 232-37, 1996.
3. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
4. Borgstrom P, Hillan, KJ, Sriramaro P, Ferrara N: Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralising antibody - novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56(17): 4032-29, 1996.
5. Mattern J, Koomagi R, Volm M: Association of vascular growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. B J Cancer. 73(7): 931 -4, 1996.
6. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA:. Relation of neovascularistation to metastasis of non-small cell lung cancer. Lancet 340: 145-46, 1992.
7. Yamazaki k, Abe S, Takekawa H, Sukoh N, Watanabe N, Ogura S, Nakajima 1, Isobe H et al: Tumor angiogenesis in human lung adenocarcinoma. Cancer 74(8): 2245-50, 1994.
8. Ohta Y, Watanabe Y, Oda M, Hayashi Y, Endo Y, Sasaki T: Vascular endothelial growth factor-121 mRNA expression and neomicrovessel density in primary lung caner. Oncology reports 3(4): 713-17, 1996.
9. Yamamoto Y, Toi M, Kondo S. Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T et al: Concentrations of vascular endothelial growth factor in sera of normal controls and cancer patients. Clin Cancer Res 2(5): 821-26, 1996.
10. Scheweigerer L, Neufeld G, Friedman J et al: Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325: 257-9, 1987.
11. Keck PJ, Hauser SD, Krivi G et al: Vacular permeability factor, an endothelial cell mitogen related to PDGF. Sience 246: 1309-12, 1989.
12. Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor. Mol Cell Endocrinol 46: 187, 1987.
13. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G: Structural characterization and biological functions of fibroblast growth factor. Endocrinol 8: 95-114, 1987.
14. Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, Watanabe Y, Sasaki T: Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res 2(8): 1411 -14, 1996.
15. Berger DP, Herbstritt L, Dengler WA et at: Vascular endothelial growth factor tVEGF) mRNA expression in human tumour models of different histologies. Ann Oncol 6: 817-25, 1995.
16. Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrhonen S, Alitalo K: Enhanced expression of the tie receptor tyrosine kinase messenger RNA in vascular endothelium of metastatic melanomata. Cancer Res 54: 6571-6577, 1994.
17. Thompson TC: Growth factors and oncogenes in prostate cancer. Cancer Cells 2: 845-354, 1990.
18. Li VW, Folkhert RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Folkman J et al: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344: 82-86, 1994.
19. Dirix LY, Vermulen PB, Hubens G, Benoy 1, Martin M: De Pooter C, Van Oostrom AT. Serum basic fibroblast growyh factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 7: 843-48, 1996.
20. Zimering MB, Brandhi ML, DeGrange DA, Marx J, Streeten E, Katsumata N, Muphy PR, Sato, Y et al: Circulating fibroblast rowth factor-like substance in familial multiple endocrine neoplasia type 1. J Clin Enocrin Met 70: 149-154, 1990.
21. Fujimoto K, lchimori Y, Kaikzoe T, Okajima E, Sakamoto H, Sugimura T, Terada M: Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 180: 386-392, 1991.
22. Sliutz G, Tempfer C, Obermair A, Reinthaller a, Gitsch G, Kainz Ch: Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Letters 94: 227-231, 1995.
23. Meyer G, Yu E, Siegal J, Petteway J, Blumenstein B, Brawer M: Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76: 2304-. 2311, 1995.
24. Sliutz G, Tempfer C, Obermair A, Dadak Ch, Kainz Ch: Serum evaluation of basic FGF in breast cancer patients. Anticancer Res 15: 2675-2678,1995.
25. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-6, 1971.
26. Folkman J, Cole P, Zimmerman S: Tumor behavior in isolated perfused organs: in vitro growth and metastasis of biopsy material in rabbit thyroid and canine intestinal segmant. Ann Surg 164: 491-502, 1966.
27. Brawer MK, Jonsson E, Gibbons RP, Deering RE, Bigler SA, Preston SD. Extent of prostate neovascularity predicts progression in patients with pathologic stage c adenocarcinoma treated with radical prostatectomy. (Abstract). J Urol 151: 289, 1994.
28. Chodak GW, Haudenschild C, Gittes RF, Folkman J. Angiogenic activity as al'narker of neoplastic lesions of the bladder. Ann Surg 192: 762-71, 1980.
29. Sillman F, Boyce J, Frutcher R: The significance of atypical vessels and neovascularization in cervical neoplasms. Am J Obstet Gynecol 739: 154-9, 1981.
30. Srivatstava A, Laidler P, Davies R, Morgan K, Hughes L: The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 133: 419-23, 1988.
31. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26301-26307, 1992.
32. Inoue Y, King T, Tinkle Sm Dockstader K, Newman L: Human mast cell basic fibroblast growth factor in pulmonary fibrotic disoreders. Am J Pathol 149: 2037-2054, 1996.
33. Al-Achkar W, Sabatier L, Dutrillaux B: Influence of time and cell cycle phase on radiation-induced chromosome lesions.. Ann Genet 31: 2:87-90, 1988.
34. Geard CR; Jones JM: Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 29:3: 565-9, 1994.
35. Wang H, Rubin M, Fenig E, DeBlasio A, Mendelsohn J, Yahalom J, Wieder R: Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. Cancer Res May 1 ;57(9): 1750-1757, 1997.